Preliminary experience with use of a selective 5HT3 receptor antagonist (ondansetron) to prevent high dose chemotherapy induced emesis.
Indian J Cancer
; 33(1): 17-20, 1996 Mar.
Article
em En
| MEDLINE
| ID: mdl-9063013
ABSTRACT
Ondansetron was used as an antiemetic along with dexamethasone during 16 cycles of highly or moderately ematogenic chemotherapy. There was major control in two cycles and complete control in the remaining 14. Side effects were minor and did not require discontinuation of the drug. This combination, therefore, appears to be safe and effective in preventing chemotherapy induced emesis.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Antagonistas da Serotonina
/
Vômito
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Receptores de Serotonina
/
Ondansetron
/
Antieméticos
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Indian J Cancer
Ano de publicação:
1996
Tipo de documento:
Article